FierceBiotech

Cognito reaps $105M in series C funding for its Alzheimer's device

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...
Forbes

$105 Million Brings Cognito, And Neurotech, to a Pivotal Stage

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...
Pharm Exec

Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing

Series C proceeds position Spectris for pivotal top-line data, regulatory submission, and launch planning ahead of a targeted 2027 U.S. market entry. Spectris delivers coordinated visual and auditory ...
Investopedia

SEC Form 15: What it Means, How it Works, Example

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
PC Magazine

Sick of Commercials? You Can Still Skip YouTube Ads (if You Try Hard Enough)

If you immediately hit the Skip Ads, it's no longer considered, as YouTube calls it, an "engaged-view conversation," and the creator won't receive any of the ad money that would be owed to them if you ...